cbdMD, Inc. (YCBD) stock
YCBDNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/3081% below fair value
$0.37+0.01 (+2.77%)
Close on Nov 18, 2026Market cap $4.19MP/E –Yield –
cbdMD net income
Net income is the profit left for shareholders after every expense, interest and tax.
cbdMD's net income for the twelve months ending Jun 30, 2026 was -$2.89M. For fiscal 2025 it was -$2.04M. The highest annual figure on record is $12.60M in fiscal 2020.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$2.04M | – |
| FY2024 | Sep 30, 2024 | -$3.70M | – |
| FY2023 | Sep 30, 2023 | -$22.94M | – |
| FY2022 | Sep 30, 2022 | -$70.08M | – |
| FY2021 | Sep 30, 2021 | -$23.39M | -285.6% |
| FY2020 | Sep 30, 2020 | $12.60M | – |
| FY2019 | Sep 30, 2019 | -$51.36M | -81835.3% |
| FY2018 | Sep 30, 2018 | $62.83K | – |
| FY2017 | Sep 30, 2017 | -$1.39M | – |
| FY2016 | Sep 30, 2016 | -$3.90M | – |
Quarterly net income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | -$1.13M | – |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | -$797.98K | – |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | -$283.13K | -1975.7% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | -$679.97K | – |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | -$895.27K | -294.7% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | -$480.76K | – |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $15.10K | – |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | -$152.80K | – |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $459.74K | – |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | -$3.01M | – |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | -$996.50K | – |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | -$15.87M | – |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | -$1.77M | – |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | -$1.34M | – |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | -$3.96M | -357.3% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | -$14.63M | – |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | -$31.63M | – |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | -$2.92M | – |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $1.54M | – |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | -$12.51M | -184.1% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | -$9.40M | -172.7% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | -$6.26M | -152.7% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | -$8.95M | – |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $14.88M | – |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $12.93M | – |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $11.88M | – |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | -$29.20M | -5266.4% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | -$31.85M | -2038.6% |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | -$2.19M | – |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | -$880.56K | – |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $565.25K | – |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $1.64M | – |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | -$1.26M | – |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | -$258.56K | – |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | -$141.91K | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | -$288.20K | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | -$697.50K | – |
See a number that looks wrong?